Mohamed Mostafa: Hosting a Movember event at Johnson and Johnson Innovative Medicine
Mohamed Mostafa, Sales Manager Oncology at The Janssen Pharmaceutical Companies of Johnson & Johnson, posted on LinkedIn:
“Today marks an exceptional moment as we host our Movember event at Johnson and Johnson Innovative Medicine Egypt.
Together, our mission is clear: to raise awareness and ultimately save more lives by emphasizing the importance of men’s health, particularly in the fight against prostate cancer—one of the most common cancers among men.
For over a decade, Johnson and Johnson has been at the forefront of prostate cancer innovation. Since our first approval in 2011, we’ve leveraged our deep expertise and patient-centric approach to transform the trajectory of prostate cancer. Our unwavering commitment drives us to continue advancing research and development, making meaningful improvements in patient care, and bringing us one step closer to a cure .
As leaders in Oncology, we are proud to deliver effective therapies to each patients at the right time of the disease.
This Movember, we stand united to inspire action, raise awareness, and create a future where prostate cancer no longer takes lives.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023